Law360 ( January 10, 2011, 4:00 PM EST) -- In Ariad Pharmaceuticals Inc. v. Eli Lilly and Company (Ariad), the Court of Appeals for the Federal Circuit confirmed the existence of a written description requirement separate from the enablement requirement. Ariad Pharmaceuticals Inc. v. Eli Lilly and Company, 598 F.3d 1336 (Fed. Cir. 2010)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.